Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
524.00    4.00 (0.77%)
Bid:
524.00
Ask:
528.00
Spread: 4.00 (0.763%)
Market Cap: £867.04m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Flash update from Kepler Trust Intelligence

27 Jan 2022 13:40

RNS Number : 8898Z
Oakley Capital Investments Limited
27 January 2022
 

Oakley Capital Investments (OCI)

27/01/2022

 

Flash update from Kepler Trust Intelligence

Oakley Capital Investments' (OCI) NAV at 31 December 2021 was 538p. This represents an increase of 21% since 30 June 2021, and brings the total NAV return for 2021 as a whole to 35%.

OCI has a relatively concentrated underlying portfolio of growth companies in three sectors: technology, education and consumer. The largest contributions to returns over the past six months were from IU Group (12.3% of NAV at 30/06/2021) which continued to see strong growth in student enrolments during the period, and TechInsights (3.2% of NAV at 31/06/2021), whose sale has been agreed at a c. 125% premium to the June book value.

The wider portfolio enjoyed strong earnings growth, benefitting from accelerating long-term trends such as the increasing adoption of digital solutions by businesses and consumers, and growing demand for quality, accessible education. During the year, 76% of the increase in the portfolio's value (including realisations) was driven by EBITDA growth and 24% by multiple expansion. Underlying activity has been strong, with cash proceeds received during the year of c. £121m and investments made of £137m. OCI had cash on the balance sheet of £163 million at 31 December 2021, representing 17% of NAV, and no debt. Total outstanding commitments at the year-end were £740 million when including the initial commitment to Fund V announced post year-end.

Kepler View

The NAV announcement represents a very strong second half for OCI. A NAV total return of 35% over 2021 compares to the FTSE World Index return of 18.9%, representing a hefty level of outperformance. Over the year, OCI's discount has narrowed, such that total shareholder returns over 2021 were 48%. OCI aims to be the first institutional investor in a company, and aside from supporting management to grow revenue and earnings rapidly, the team also aim to "professionalise" these businesses, making them ideal subsequent targets for other private equity investors. The recent deal to sell (and reinvest in) TechInsights to CVC Growth Funds, provides evidence that this strategy is working.

 

OCI has a significant cash balance (17% of NAV at 31/12/2021). Outstanding commitments (at the year end) of £740m may look optically high. However a good proportion of historic outstanding commitments are unlikely to be called. In our view the €400m commitment to Oakley's Fund V shows the board's confidence in future cash flows from realisations (average maturity of the current portfolio being between 3.5 - 4 years) and investment activity. It is also worth noting that the Fund V commitment is expected to be deployed over the next five years.

 

We think Oakley's focus and expertise in specific sectors, its proven ability to source investments (platform or bolt-on) through its proprietary network of entrepreneurs and its discipline in terms of pricing and valuations means OCI is highly differentiated from peers. Going forward, OCI will make quarterly NAV announcements, which we view as a good step forward in helping investors better understand the NAV trajectory, and over time potentially this could be helpful in achieving a narrower discount. We expect more detail on the underlying portfolio when OCI reports its annual results on Thursday 10 March 2022.

 

CLICK HERE TO READ THE FULL REPORT

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKOBNNBKDODB
Date   Source Headline
15th Dec 20217:00 amRNSSale of TechInsights and follow-on investment
2nd Dec 202110:30 amEQSHardman Talks | Oakley Capital Investments Webinar: Everything you wanted to know about private equity but were afraid to ask!
1st Dec 202112:45 pmEQSHardman & Co: Hardman Talks Video Event | Oakley Capital Investments Live Q&A Webinar
25th Oct 20212:30 pmEQSHardman & Co Research: Q&A on Oakley Capital Investments (OCI) | Pipeline looks strong with new deals being announced regularly
21st Sep 20212:06 pmRNSDirector Dealing
14th Sep 20217:00 amRNSOakley Capital invests in Seedtag
13th Sep 20213:41 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): 1H'21: 35% EBITDA growth drives 26% NAV return
9th Sep 20217:00 amRNSResults for the Six Months ended 30 June 2021
25th Aug 20217:00 amRNSNotice of Interim Results and Webcast Presentation
23rd Aug 20211:13 pmRNSHolding(s) in Company
13th Aug 20212:09 pmRNSHolding(s) in Company
12th Aug 202112:16 pmRNSHolding(s) in Company
2nd Aug 202112:37 pmRNSHolding(s) in Company
30th Jul 20215:57 pmRNSHolding(s) in Company
30th Jul 202111:29 amRNSHolding(s) in Company
29th Jul 20215:32 pmRNSTransaction in Own Shares
29th Jul 20217:00 amRNSShare Buy-Back Programme
28th Jul 20217:00 amRNSTrading Update for the Six Months Ended 30 June 21
27th Jul 20217:00 amRNSResult of AGM
21st Jul 202112:46 pmRNSHolding(s) in Company
1st Jul 202112:22 pmRNSChange of Administrator
29th Jun 20218:55 amRNSKepler Trust Intelligence: New Research
28th Jun 20217:00 amRNSSale of ACE Education and follow-on investment
28th Jun 20217:00 amRNSNotice of Annual General Meeting
24th Jun 20215:56 pmRNSHolding(s) in Company
24th Jun 20215:52 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSDirector Dealing
22nd Jun 20217:00 amRNSInvestment in Primavera
11th Jun 20217:30 amEQSHardman & Co Research: Hardman & Video | Q&A with Mark Thomas on Oakley Capital Investment (OCI)
7th Jun 20217:00 amRNSInvestment in Afterbuy and DreamRobot
3rd Jun 20214:50 pmRNSHolding(s) in Company
1st Jun 20217:00 amRNSInvestment in ICP Education
25th May 20211:40 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): 2021 Capital Markets day: proof of the pudding
13th May 20215:25 pmRNSHolding(s) in Company
30th Apr 20214:29 pmRNSHolding(s) in Company
30th Apr 20213:29 pmRNSHolding(s) in Company
22nd Apr 20218:42 amRNSHolding(s) in Company
21st Apr 20217:00 amRNSCapital Markets Day
16th Apr 20213:54 pmRNSHolding(s) in Company
12th Apr 20214:03 pmRNSHolding(s) in Company
30th Mar 20219:10 amEQSHardman & Co Research : Hardman Talks Video | Oakley Capital Investments
22nd Mar 20219:30 amRNSHardman & Co: Sustained and sustainable NAV growth
15th Mar 20215:35 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
9th Mar 20212:05 pmEQSHardman & Co Research : Hardman Talks | Oakley Capital Investments Management Discussion
1st Mar 20217:00 amRNSRefinancing of Career Partner Group
23rd Feb 20217:00 amRNSNotice of Results and Investor Presentation
19th Feb 20217:00 amRNSInvestment in Dexters
10th Feb 20217:00 amRNSDirector Dealing
29th Jan 20214:42 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.